An update on cefepime and its future role in combination with novel β-lactamase inhibitors for MDR Enterobacterales and Pseudomonas aeruginosa–—authors’ response

Subjects

Subjects :

Pharmacology
Microbiology (medical)
Pseudomonas aeruginosa
business.industry
Cefepime
Microbial Sensitivity Tests
medicine.disease_cause
Cephalosporins
Microbiology
Infectious Diseases
β lactamase inhibitor
Enterobacterales
medicine
Pharmacology (medical)
beta-Lactamase Inhibitors
business
medicine.drug

Details

ISSN :

14602091 and 03057453

Volume :

76

Database :

OpenAIRE

Journal :

Journal of Antimicrobial Chemotherapy

Accession number :

edsair.doi.dedup.....0ab0753dbc0e4bca3490e6a807babf27